Phase II Study of ASP0456 - A Double-blind, Placebo-controlled, Parallel-group, Comparative Study in Patients With Chronic Constipation (Not Including Constipation Due to Organic Diseases)
Latest Information Update: 14 Jan 2020
Price :
$35 *
At a glance
- Drugs Linaclotide (Primary)
- Indications Constipation
- Focus Therapeutic Use
- Sponsors Astellas Pharma
- 09 May 2017 Primary endpoint (Change in weekly average of SBM frequency) has been met as per the results presented at the Digestive Disease Week 2017
- 09 May 2017 Results presented at the Digestive Disease Week 2017
- 01 May 2017 According to an Ironwood Pharmaceuticals media release, data from this trial will be presented at the Digestive Disease Week 2017.